Kaken Pharmaceutical Overview

Life ScienceCompany

Where is Kaken Pharmaceutical headquartered?

Kaken Pharmaceutical is headquartered in Tokyo, Japan.

What is Kaken Pharmaceutical’s revenue?

Kaken Pharmaceutical disclosed revenue of 94,035M JPY for 2025 and 72,044M JPY for 2024.

How many employees does Kaken Pharmaceutical have?

Kaken Pharmaceutical has 1,126 employees.

What sector is Kaken Pharmaceutical in?

Kaken Pharmaceutical is a life science company.

When was Kaken Pharmaceutical founded?

Kaken Pharmaceutical was founded in 1948.

Kaken Pharmaceutical

Kaken Pharmaceutical Co., Ltd.

28-8, Honkomagome 2-chome Bunkyo-ku,
Tokyo, 113-8650
Japan,
+81 3 5977 5007
www.kaken.co.jp

Kaken Pharmaceutical is a specialty and generic drug manufacturing company. The Company's products are mainly for nervous, circulatory, respiratory, digestive, urinary, sensory, and metabolic systems. Kaken Pharmaceutical was founded in 1948 and is based in Tokyo, Japan.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # - - - - - 1 1
vol $100M $100M
Sell (0.0/yr) # - - - - - - 0
  1

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Kaken Pharmaceutical

Life Science Companies , Japan Companies